Suppr超能文献

无皮质类固醇维持免疫抑制改善心脏移植后的体重增加。犹他心脏移植项目。

Amelioration of weight gain after heart transplantation by corticosteroid-free maintenance immunosuppression. UTAH Cardiac Transplant Program.

作者信息

Hagan M E, Holland C S, Herrick C M, Rasmussen L G

机构信息

Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, University of Utah Medical Center, Salt Lake City.

出版信息

J Heart Transplant. 1990 Jul-Aug;9(4):382-4.

PMID:2398433
Abstract

After heart transplantation, recipients frequently become obese. Although the cause is undoubtedly multifactorial, administration of corticosteroids may contribute to posttransplant obesity. To test this hypothesis, we retrospectively reviewed the change in body weight with respect to corticosteroid use after transplantation in all 110 recipients surviving 1 year in the UTAH Cardiac Transplant Program. Fifty-two recipients (47%, group 1) were unable to be withdrawn from maintenance corticosteroids, and 58 recipients (53%, group 2) were successfully withdrawn, the latter group requiring only cyclosporine and azathioprine long-term maintenance immunosuppression. The change in weight from the time of transplantation to 1 year after transplantation in group 1 was 8.7 +/- 1.1 kg; group 2 patients gained only 4.9 +/- 0.9 kg (p = 0.009). In conclusion, successful withdrawal of maintenance corticosteroids after heart transplantation decreased posttransplant weight gain, suggesting that posttransplant obesity is in part related to use of corticosteroids.

摘要

心脏移植后,受者常常会出现肥胖。尽管其原因无疑是多因素的,但使用皮质类固醇可能导致移植后肥胖。为验证这一假设,我们回顾性分析了犹他心脏移植项目中存活1年的110例受者移植后使用皮质类固醇与体重变化的关系。52例受者(47%,第1组)无法停用维持剂量的皮质类固醇,58例受者(53%,第2组)成功停用,后一组仅需长期使用环孢素和硫唑嘌呤进行维持性免疫抑制。第1组从移植时到移植后1年体重增加8.7±1.1千克;第2组患者仅增加4.9±0.9千克(p = 0.009)。总之,心脏移植后成功停用维持剂量的皮质类固醇可减少移植后体重增加,提示移植后肥胖部分与皮质类固醇的使用有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验